Default company panoramic image

MitoDys Therapeutics ltd

Big Data and informatics-derived multi-targeted drugs as disease modifying agents for neurodegenerative diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Oxford, United Kingdom
  • Currency GBP
  • Founded September 2012
  • Employees 4
  • Incorporation Type Other
  • Website

Company Summary

Mitodys is a capital-efficient drug discovery start-up focused on uncovering proprietary drugs with profiles that allow them to be repositioned to a new indication. Its focus is on the discovery of disease-modifying agents for the treatment of neurodegenerative diseases using a systems-targeted approach which represents a new paradigm in drug discovery. The diseases targeted remain poorly- or unmet needs valued in the billions of US dollars.


  • Afe17006 4e15 4d37 b9da 658c31c9e83a
    Founder and CEO

    Trained Scientist (Biochemistry, Molecular Biology and Genetics) and ex-Wall Street and City (F.Eberstadt, Flemings, DLJ and CSFB). Co-founder of companies (Orthomatrix, Steribottle, Tissuomics and Protein Sciences) and consulted for various companies (Ascom, e-Therapeutics and Selventa amongst others)

  • Default avatar
    Simon Bennett
    Director and Business Development

    DPhil in Human genetics and former Wellcome Trust Research fellow who is a highy experienced Biotech executive having worked for Oxagen, Solexa and Glide Pharma. Consultant to Menarini Biotech and Director of colwiz

  • CFO of Oxford Biomedica for 17 years. BSc in Biochemistry from Oxford University and ACA.

  • A20be80c 214a 45a7 a571 718e111e5490
    Director and Chief Legal Advisor

    Trained business lawyer who runs a technology and biotech law practice in Oxford UK


  • Default avatar
    Simon Smith/Taveners
    Default avatar
    James Cowper

Previous Investors

  • Default avatar
    The Life Neurological Research Trust
    Default avatar
    Alex Gerko
    Cf1991f9 19c3 4051 becf c0725ccf4a59
    Quant Trader
  • Default avatar
    Juliet Telford
    Private Investor